Sequenom

Sequenom shares declined 2.44 percent to close at $2.76 a share Monday. The stock traded between $2.73 and $2.82 on volume of 2.99 million shares traded. The company announced that its Board of Directs has authorized “a review of potential strategic alternatives for its Genetic Analysis business segment.” Shares of Sequenom have gained approximately 38.0 percent year-to-date.